loadpatents
name:-0.0228111743927
name:-0.011440992355347
name:-0.0026898384094238
Aguirre; Gustavo D. Patent Filings

Aguirre; Gustavo D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aguirre; Gustavo D..The latest application filed is for "aav vectors for treatment of dominant retinitis pigmentosa".

Company Profile
2.9.16
  • Aguirre; Gustavo D. - Media PA
  • Aguirre; Gustavo D - Philadelphia PA
  • AGUIRRE; Gustavo D. - Philadelphia PA
  • Aguirre; Gustavo D. - Ithaca NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa
App 20210324387 - Lewin; Alfred S. ;   et al.
2021-10-21
AAV vectors for treatment of dominant retinitis pigmentosa
Grant 11,118,185 - Lewin , et al. September 14, 2
2021-09-14
Compositions And Methods For Treatment Of Dominant Retinitis Pigmentosa
App 20210207147 - Lewin; Alfred S. ;   et al.
2021-07-08
AAV-mediated gene therapy for RPGR X-linked retinal degeneration
Grant 10,383,922 - Beltran , et al. A
2019-08-20
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa
App 20190093111 - Lewin; Alfred S. ;   et al.
2019-03-28
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration
App 20180036385 - BELTRAN; William A. ;   et al.
2018-02-08
AAV-mediated gene therapy for RPGR X-linked retinal degeneration
Grant 9,770,491 - Beltran , et al. September 26, 2
2017-09-26
Method of Treating or Retarding the Development of Blindness
App 20170014529 - Acland; Gregory M. ;   et al.
2017-01-19
Method of Treating or Retarding the Development of Blindness
App 20160263246 - Acland; Gregory M. ;   et al.
2016-09-15
Method of treating or retarding the development of blindness
Grant 9,433,688 - Acland , et al. September 6, 2
2016-09-06
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration
App 20150202269 - Beltran; William A ;   et al.
2015-07-23
Method of Treating or Retarding the Development of Blindness
App 20140377224 - Acland; Gregory M. ;   et al.
2014-12-25
Method Of Treating Or Retarding The Development Of Blindness
App 20130216500 - Acland; Gregory M. ;   et al.
2013-08-22
Method Of Treating Or Retarding The Development Of Blindness
App 20120225930 - Acland; Gregory M. ;   et al.
2012-09-06
Method of treating or retarding the development of blindness
Grant 8,147,823 - Acland , et al. April 3, 2
2012-04-03
Method Of Treating Or Retarding The Development Of Blindness
App 20100272688 - Acland; Gregory M. ;   et al.
2010-10-28
Method for identifying progressive rod-cone degeneration in dogs
Grant 7,811,761 - Acland , et al. October 12, 2
2010-10-12
Diagnostic test for Collie Eye Anomaly
Grant 7,723,507 - Acland , et al. May 25, 2
2010-05-25
Diagnostic Test For Collie Eye Anomaly
App 20090176225 - Acland; Gregory M. ;   et al.
2009-07-09
Method of Treating or Retarding the Development of Blindness
App 20090074723 - Acland; Gregory M. ;   et al.
2009-03-19
Diagnostic test for collie eye anomaly
Grant 7,462,455 - Acland , et al. December 9, 2
2008-12-09
Method for identifying progressive rod-cone degeneration in dogs
App 20070161033 - Acland; Gregory M. ;   et al.
2007-07-12
Method of treating or retarding the development of blindness
App 20070077228 - Acland; Gregory M. ;   et al.
2007-04-05
Diagnostic test for Collie Eye Anomaly
App 20060115843 - Acland; Gregory M. ;   et al.
2006-06-01
Identification of congenital stationary night blindness in dogs
Grant 6,428,958 - Aguirre , et al. August 6, 2
2002-08-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed